Objectivity in Research - NIH GUIDE, Volume 24, Number 25, July 14, 1995. Provides regulations establishing standards and procedures to be followed by institutions that apply for research to ensure that the design, conduct, or reporting of research funded under PHS grants, cooperative agreements or contracts will not be biased by any conflicting financial interest of those investigators responsible for the research.

Frequently Asked Questions - concerning the Department of Health and Human Services Objectivity in Research Regulations and the National Science Foundation's Investigator Financial Disclosure Policy.

Financial Disclosure by Clinical Investigators (FDA) - This final rule requires applicants to certify to the absence of certain financial interests of clinical investigators or to disclose those financial interests. If the applicant does not include a certification and/or disclosure, or does not certify that it was not possible to obtain the information, the agency may refuse to file the application.

Conflict of Interest: Canadian Tri-Council Policy Statement - on ethical considerations of human-subjects research. Includes policies on conflicts of interest for researchers, review board members, and institutions.

Conflict-of-Interest Policies for Clinical Investigators - The New England Journal of Medicine.

Financial Associations of Authors - The New England Journal of Medicine announces revisions to its policies on financial associations of authors, 6/13/02.

Ethical Issues in CME, Clinical Research- Discussion and case studies of issues involving conflict-of-interest, for example, gifts from pharmaceutical companies and recommending patients for clinical trials.

Report on Individual and Institutional Financial Conflict of Interest- issued by the Association of American Universities (AAU)